True-Isothermal Plasmid Amplication System

Information

  • Research Project
  • 6882829
  • ApplicationId
    6882829
  • Core Project Number
    R43GM073402
  • Full Project Number
    1R43GM073402-01
  • Serial Number
    73402
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/14/2005 - 19 years ago
  • Project End Date
    3/31/2006 - 18 years ago
  • Program Officer Name
    PORTNOY, MATTHEW
  • Budget Start Date
    3/14/2005 - 19 years ago
  • Budget End Date
    3/31/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/11/2005 - 19 years ago
Organizations

True-Isothermal Plasmid Amplication System

DESCRIPTION (provided by applicant): Amplification and detection of specific target sequences from DMA and RNA is a fundamental tool for diagnostics and biomedical research. We have devised a new isothermal DMA amplification method which can be used to amplify circular DMA molecules, by mimicking nature in terms of DNA replication. Our method, circular Helicase-Dependent Amplification (c-HDA), uses a DNA helicase to separate two strands of a duplex DNA followed by a DNA polymerase to copy the target sequence. Our c-HDA technology has several advantages. First, it is a true-isothermal reaction and the entire amplification reaction can be carried out in one temperature since helicases are able to separate duplex DNA enzymatically even without prior denaturation. This offers potential for the development of rapid and simple DNA diagnostic methods that could be used to detect pathogens containing circular plasmids such as Bacillus anthracis at point-of-care or in the field. Second, our method can amplify both the specific target sequence flanked by two primers and the entire circular DNA. Plasmid DNA purification and analysis is an essential step for DNA cloning, sequencing and screening. If successfully developed, our c-HDA method may be used as a one-tube/one-step process to substitute time-consuming and labor-intensive steps of cell-culturing, purifying and analyzing plasmid DNA. Although we have established the feasibility of using c-HDA to amplify plasmid DNA the current HDA systems are not robust enough to be commercialized in marketplace. The technical risk barriers are 1) long amplification time (3-6 hours); 2) low sensitivity; 3) false - positive (non-specific amplification). Although the risk and uncertainty are high, we present good evidences based on our preliminary research and other published observations that it is feasible to further our technical advantage to over come technical risk barriers through proposed research.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    98208
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:98208\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOHELIX CORPORATION
  • Organization Department
  • Organization DUNS
    169510950
  • Organization City
    BEVERLY
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01915
  • Organization District
    UNITED STATES